FELSHER STEVEN G 4

What Happened

• Steven G. Felsher, a director of Modular Medical, Inc. (MODD), was granted equity as outside director compensation on March 31, 2026: 25 shares of common stock and a derivative award for 250 shares (reported as a grant/award).
• No purchase price or cash exchanged is reported (prices shown as N/A); these were compensation awards rather than open-market purchases or sales. The awards reflect the issuer’s Outside Director Compensation Plan and the derivative option was fully vested and exercisable on the grant date.

Key Details

• Transaction date: March 31, 2026; Form 4 filed April 8, 2026 (filed more than two business days after the transaction — appears late).
• Awards: 25 shares (issued) and a derivative award for 250 shares (option/derivative); reported dollar prices: N/A.
• Footnotes of note:
  • F1: Shares issued under the Issuer’s Outside Director Compensation Plan.
  • F2: Reported share amounts reflect a 1-for-30 reverse stock split effective March 31, 2026.
  • F3: The option was granted in accordance with the plan and was fully vested and exercisable on the grant date.
  • F4: Column reporting rules for derivative securities (total beneficial ownership by class) apply.
• Shares owned after the transaction and any exercise price for the option are not specified in the filing.

Context

• These entries are compensation grants (routine for non-employee directors) rather than purchases or sales; they do not directly signal buying or selling sentiment.
• The derivative entry is an option-like award that was fully vested on grant — it represents the right to acquire shares but does not necessarily mean the shares were exercised or sold.
• The filing delay may warrant attention by investors interested in insider reporting timeliness; late Form 4s can draw regulatory scrutiny or indicate reporting oversights but do not by themselves imply misconduct.